Your browser is no longer supported. Please, upgrade your browser.
Settings
ADVM Adverum Biotechnologies, Inc. daily Stock Chart
ADVM [NASD]
Adverum Biotechnologies, Inc.
Index- P/E- EPS (ttm)-1.12 Insider Own11.22% Shs Outstand66.89M Perf Week2.22%
Market Cap769.90M Forward P/E- EPS next Y-1.17 Insider Trans0.27% Shs Float56.04M Perf Month41.57%
Income-69.90M PEG- EPS next Q-0.29 Inst Own75.20% Short Float8.19% Perf Quarter103.72%
Sales1.40M P/S549.93 EPS this Y-12.40% Inst Trans2.58% Short Ratio7.06 Perf Half Y214.48%
Book/sh2.98 P/B3.86 EPS next Y-7.60% ROA-30.80% Target Price5.88 Perf Year107.39%
Cash/sh2.83 P/C4.06 EPS next 5Y- ROE-33.40% 52W Range2.62 - 11.83 Perf YTD265.40%
Dividend- P/FCF- EPS past 5Y-36.80% ROI-38.20% 52W High-1.10% Beta2.40
Dividend %- Quick Ratio18.20 Sales past 5Y27.40% Gross Margin- 52W Low346.56% ATR0.64
Employees78 Current Ratio18.20 Sales Q/Q- Oper. Margin- RSI (14)73.51 Volatility6.26% 6.33%
OptionableYes Debt/Eq0.00 EPS Q/Q23.40% Profit Margin- Rel Volume0.92 Prev Close11.51
ShortableYes LT Debt/Eq0.00 EarningsMay 08 Payout- Avg Volume650.42K Price11.70
Recom2.50 SMA2013.49% SMA5047.39% SMA200120.41% Volume598,146 Change1.65%
Jun-14-19Resumed Raymond James Mkt Perform
Nov-02-18Downgrade SunTrust Buy → Hold
Nov-02-18Downgrade Raymond James Outperform → Mkt Perform
Sep-21-18Initiated Cantor Fitzgerald Overweight
Aug-30-18Initiated SunTrust Buy $11
Feb-15-18Resumed Piper Jaffray Overweight $12
Oct-12-17Initiated Raymond James Outperform $6
Jun-10-19 09:00AM  Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD GlobeNewswire
May-24-19 09:44AM  Adverum Biotechnologies, Inc. (ADVM) Shares March Higher, Can It Continue? Zacks
May-22-19 11:34AM  Biotech Stock Roundup: Label Expansion for CELG's Drugs, Setback for IMGN Zacks
May-20-19 04:14PM  Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study Zacks
May-19-19 09:00AM  3 Biotech Stocks That Soared Last Week: Are They Buys? Motley Fool
May-17-19 08:00PM  Tallgrass Energy Barrons.com +11.32%
09:00AM  All You Need to Know About Adverum Biotechnologies (ADVM) Rating Upgrade to Buy Zacks
08:03AM  The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering Benzinga
May-16-19 09:00AM  Adverum Biotechnologies Provides Update on OPTIC Phase 1 Trial for ADVM-022 in Wet AMD GlobeNewswire +26.05%
May-11-19 02:36AM  Tilray (TLRY) to Report Q1 Earnings: What's in the Cards? Zacks
May-10-19 03:45PM  Tilray (TLRY) to Report Q1 Earnings: What's in the Cards? Zacks
May-08-19 05:15PM  Adverum Biotechnologies (ADVM) Reports Q1 Loss, Lags Revenue Estimates Zacks -5.45%
04:08PM  Adverum Biotechnologies: 1Q Earnings Snapshot Associated Press
04:00PM  Adverum Biotechnologies Reports First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
11:39AM  Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store? Zacks
May-02-19 04:30PM  Adverum Biotechnologies Announces Board Changes GlobeNewswire
06:00AM  Adverum Biotechnologies to Present 30-month Preclinical Safety and Expression Data for ADVM-022 Gene Therapy in Wet AMD at the ASGCT 22nd Annual Meeting GlobeNewswire
May-01-19 10:33AM  Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-30-19 01:30PM  Adverum Biotechnologies Presents First Preclinical Data on Dosing Contralateral Eye with ADVM-022 Gene Therapy for Wet AMD at the ARVO 2019 Annual Meeting GlobeNewswire
Apr-28-19 10:50PM  Is a Beat in the Offing for Humana's (HUM) Q1 Earnings? Zacks
Apr-25-19 07:58AM  The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings Benzinga
Apr-24-19 04:00PM  Adverum Biotechnologies Appoints Thomas Leung as Chief Financial Officer GlobeNewswire
Apr-17-19 07:48AM  The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO Benzinga
Apr-16-19 04:00PM  Adverum Biotechnologies to Present New Preclinical Data on ADVM-022 Gene Therapy for Wet AMD at ASGCT and ARVO GlobeNewswire
Apr-15-19 09:00AM  Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD GlobeNewswire +11.57%
Apr-05-19 12:25PM  What Kind Of Shareholders Own Adverum Biotechnologies, Inc. (NASDAQ:ADVM)? Simply Wall St.
Apr-01-19 04:01PM  Adverum Biotechnologies Appoints Ophthalmology Industry Veteran Aaron Osborne, MBBS MRCOphth, as Chief Medical Officer GlobeNewswire
Mar-18-19 09:00AM  Adverum Biotechnologies to Participate in Upcoming Conferences GlobeNewswire +5.02%
Mar-12-19 10:50AM  Adverum Biotechnologies (ADVM) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Mar-06-19 04:10PM  Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Feb-28-19 04:10PM  Adverum to Present at the Cowen 39th Annual Health Care Conference GlobeNewswire -7.32%
Feb-13-19 04:10PM  Adverum to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-11-19 08:30AM  Adverum Biotechnologies Announces Presentation of Preclinical Long-Term Safety Data of ADVM-022 at 2019 Angiogenesis, Exudation, and Degeneration Conference GlobeNewswire +5.71%
Jan-30-19 07:30AM  Report: Developing Opportunities within Waste Connections, Performance Food Group, HealthEquity, PS Business Parks, Adverum Biotechnologies, and Bellicum Pharmaceuticals Future Expectations, Projections Moving into 2019 GlobeNewswire
Jan-06-19 08:00PM  Adverum Biotechnologies Provides 2019 Outlook GlobeNewswire
Dec-20-18 08:30AM  Adverum to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire -6.41%
Dec-12-18 04:32AM  What Bargains? Play 5 Stocks With Rising P/E Instead Zacks
01:09AM  Is Adverum Biotechnologies, Inc. (ADVM) A Good Stock To Buy? Insider Monkey
Dec-03-18 04:10PM  Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources GlobeNewswire
08:30AM  Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy GlobeNewswire
Nov-19-18 08:30AM  Adverum Announces First Patient Dosed in OPTIC Phase 1 Trial of ADVM-022 Gene Therapy in Wet Age-Related Macular Degeneration GlobeNewswire
Nov-13-18 04:30PM  Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-08-18 08:30PM  Adverum Biotechnologies (ADVM) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:30PM  Adverum Biotechnologies: 3Q Earnings Snapshot Associated Press
04:10PM  Adverum Biotechnologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
07:50AM  Investor Expectations to Drive Momentum within Consolidated Edison, MUELLER WATER PRODUCTS, Adverum Biotechnologies, Buckeye Partners, inTest, and Live Nation Entertainment Discovering Underlying Factors of Influence GlobeNewswire
Nov-07-18 10:30AM  Adverum Biotechnologies (ADVM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Nov-02-18 03:12PM  Here's Why Adverum Biotechnologies Dropped as Much as 42.4% Today Motley Fool -26.59%
12:15PM  Apple, Cirrus Logic, GoPro, and More: Heres Why These Stocks Are On the Move Insider Monkey
08:01AM  The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug Benzinga
Nov-01-18 04:15PM  Adverum Biotechnologies Provides Program Updates GlobeNewswire +8.33%
Oct-18-18 07:56AM  The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs Benzinga -6.75%
Oct-17-18 04:10PM  Adverum Biotechnologies Announces Appointment of Leone Patterson as CEO and Member of the Board of Directors GlobeNewswire
09:00AM  Adverum Biotechnologies Announces Data Presented at the European Society of Gene and Cell Therapy (ESGCT) GlobeNewswire
Oct-16-18 08:40AM  Consolidated Research: 2018 Summary Expectations for Mimecast, Shiloh Industries, Adverum Biotechnologies, AngioDynamics, Kimball Electronics, and Changyou Fundamental Analysis, Key Performance Indications GlobeNewswire
Sep-21-18 03:32PM  Cantor Fitzgerald's 7 Buys For 7 Biotechs Benzinga
Sep-20-18 09:02AM  The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut Benzinga
Sep-19-18 06:36PM  Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD GlobeNewswire
Sep-18-18 04:10PM  Adverum to Present at Cantor Global Healthcare Conference GlobeNewswire
Sep-06-18 10:46AM  Why Adverum Biotechnologies (ADVM) is a Top Pick for Momentum Investors Zacks -9.03%
Sep-04-18 10:07AM  Zacks.com highlights: American Woodmark, Adverum Biotechnologies, Merrimack Pharmaceuticals, Athene Holding and M&T Bank Zacks -7.89%
Aug-31-18 04:17AM  Can The Uptrend Continue for Adverum Biotechnologies (ADVM)? Zacks +6.29%
Aug-29-18 05:30PM  Adverum Biotechnologies Announces IND Active for ADVM-022, a Novel Gene Therapy to Treat Wet Age-related Macular Degeneration GlobeNewswire
Aug-23-18 11:39AM  7 Cheap Biotech Stocks to Buy Now InvestorPlace
Aug-20-18 08:25AM  Investor Expectations to Drive Momentum within Mazor Robotics, Kinross Gold, Mimecast, DBV Technologies S.A., Adamas Pharmaceuticals, and Adverum Biotechnologies Discovering Underlying Factors of Influence GlobeNewswire
Aug-08-18 07:45PM  Adverum Biotechnologies: 2Q Earnings Snapshot Associated Press
04:05PM  Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
Aug-01-18 04:05PM  Adverum Biotechnologies Announces Clinical Progress Across Gene Therapy Pipeline GlobeNewswire
Jul-31-18 12:17PM  What's in Store for Adverum (ADVM) This Earnings Season? Zacks
Jul-26-18 07:20AM  Free Technical Research on Advaxis and Three More Biotech Equities ACCESSWIRE
Jul-24-18 04:00PM  Adverum Biotechnologies Appoints Katherine Bock as Vice President, Investor Relations & Corporate Communications GlobeNewswire
Jun-07-18 07:45AM  Complimentary Technical Snapshots on Adverum Biotechnologies and Three More Biotech Stocks ACCESSWIRE -7.25%
Jun-04-18 09:00AM  Adverum Biotechnologies to Present at the 2018 Jefferies Global Healthcare Conference GlobeNewswire
07:55AM  Analysis: Positioning to Benefit within Kinross Gold, New York Mortgage Trust, POSCO, NXP Semiconductors N.V, Baidu, and Adverum Biotechnologies Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-18-18 08:00AM  Benzinga's Daily Biotech Pulse: AstraZeneca's Q1, Novartis-Amgen Migraine Drug Approved Benzinga
May-17-18 08:15PM  Adverum Biotechnologies Presents Additional Long-term Preclinical Data on ADVM-022 in Wet AMD at ASGCT 21st Annual Meeting GlobeNewswire
May-09-18 04:17PM  Adverum Biotechnologies: 1Q Earnings Snapshot Associated Press +5.41%
04:00PM  Adverum Biotechnologies Reports First Quarter 2018 Financial Results and Provides Corporate Update GlobeNewswire
May-07-18 01:15PM  What Are Analysts Saying About Adverum Biotechnologies Incs (NASDAQ:ADVM) Earnings Trajectory? Simply Wall St. +6.10%
07:35AM  The Zacks Analyst Blog Highlights: UnitedHealth, Envision, Addus and Adverum Zacks
May-04-18 12:11PM  Here's Why Adverum Biotechnologies Got Crushed Today Motley Fool -16.14%
May-03-18 04:30PM  Adverum Biotechnologies Announces Leadership Changes GlobeNewswire
May-01-18 10:42AM  Is a Beat in Store for Adverum (ADVM) This Earnings Season? Zacks
09:00AM  Adverum Biotechnologies Announces Long-term Preclinical Efficacy Data on ADVM-022 Gene Therapy in Wet AMD GlobeNewswire
Apr-20-18 04:42PM  Are Earnings Prospects Improving For Loss-Making Adverum Biotechnologies Incs (NASDAQ:ADVM)? Simply Wall St.
Apr-09-18 07:40AM  Research Report Identifies Teck Resources, Adverum Biotechnologies, BeiGene, IPG Photonics, Arsanis, and G1 THERAPEUTICS with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire +6.42%
Mar-14-18 11:19AM  3 Growth Stocks for In-the-Know Investors Motley Fool +5.76%
08:30AM  Research Report Identifies Pan American Silver, Ballard Power, Silvercorp Metals, SunOpta, Baidu, and Adverum Biotechnologies with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-06-18 07:15PM  Adverum Biotechnologies posts 4Q loss Associated Press
04:00PM  Adverum Biotechnologies Reports Fourth Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
Feb-26-18 09:25AM  Is a Beat in Store for Adverum (ADVM) This Earnings Season? Zacks
09:01AM  Adverum Biotechnologies to Present at Upcoming Investor Conferences GlobeNewswire
09:00AM  Adverum Biotechnologies Announces Completion of Dosing of First Cohort of Patients in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 Gene Therapy for A1AT Deficiency GlobeNewswire
Feb-12-18 04:01PM  Adverum Biotechnologies Announces Closing of $69 Million Public Offering GlobeNewswire
Feb-11-18 07:32AM  3 Growth Stocks That Could Put Shopify's Returns to Shame Motley Fool
Feb-08-18 08:00AM  Adverum Biotechnologies Announces Pricing of $60 Million Public Offering of Common Stock GlobeNewswire +5.63%
Feb-07-18 04:01PM  Adverum Biotechnologies Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-30-18 08:43AM  Adverum Biotechnologies (ADVM) Jumps: Stock Rises 7.9% Zacks +5.30%
Jan-28-18 03:28PM  3 Biotech Stocks With Jaw-Dropping Growth Potential Motley Fool
Jan-27-18 10:32AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. Its pipeline of product candidates includes ADVM-022, an adeno- associated virus (AAV). 7m8-aflibercept for the treatment of wet age-related macular degeneration; ADVM-043, an investigational gene therapy candidate for the treatment of alpha-1 antitrypsin deficiency; and ADVM-053, a preclinical gene therapy product candidate for the treatment of hereditary angioedema. The company has collaboration agreements with Editas Medicine, Inc. to leverage its proprietary AAV vectors for genome editing technologies to treat up to five inherited retinal diseases; and Regeneron Pharmaceuticals, Inc. for the development of up to eight distinct ocular therapeutic targets. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was founded in 2006 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scopa James PaulDirectorMay 06Buy6.7120,000134,20020,000May 06 07:42 PM